Less variable Yes-associated protein gene activation timing may widen safe suppression windows
After repeated skin injury, less variable timing of Yes-associated protein (YAP)-dependent gene activity may widen the suppression window that preserves strength, reversible deformation and barrier repair. A confirmed variability change without a window change would reject this as the determining mechanism.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Rhythm or programme
Transcription
The process of producing RNA from DNA through transcriptional events
Where this hypothesis actsSkin cells after repeated injury, with variable timing of YAP-dependent repair and profibrotic programs
Hypotheses on this target 1
Inhibition
Activation
Function preservation
Feedback restoration
Rhythm restoration1
Direct measurement
What is proposed
Rhythm restoration
Reduce variability in transcriptional event timing while preserving the mean response
With whatNot stated in the record
HowSeek controlled intervention regimes with comparable mean responses but different variability; specific interventions are not stated
Possible result
Possible wider safe window for YAP suppression while preserving strength, reversible deformation and barrier repair
From the recordГипотеза предсказывает, что снижение внутренней вариабельности при сохранении среднего ответа расширит общее безопасное окно без необходимости позднего YAP–p73-зависимого апоптоза.
Regulatory protein
YAP
A protein involved in tissue repair and the activation of apoptosis through interaction with p73
Where this hypothesis actsSkin after repeated injury, when repair and profibrotic programs overlap across cells
Hypotheses on this target 5- Inhibition3
- Activation2
Lower level
Higher level
Protection from degradation
Function restoration- Function preservation
What is proposed
Inhibition
Suppress YAP with an experimentally varied start time
With whatNot stated in the record
HowIndependently vary the onset of YAP suppression and transcriptional response variability; the suppression technique is not stated
Possible result
Possible prevention of scarring while preserving tissue strength and barrier repair
From the recordВ одной серии моделей независимо изменяют начало подавления YAP и вариабельность транскрипционных ответов.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Repeated skin repair may leave damage that limits how well middle-aged skin can function. The unexpected move is to target differences in the timing of cells’ responses while keeping their average response unchanged. This is a hypothesis generated by the pipeline, not a measured result: more synchronized responses are predicted to make it possible to suppress YAP without interrupting repair.
- Assembly and disassembly of gene-reading protein groups are proposed to introduce random delays into YAP-controlled gene activity.
- Repeated injury is proposed to widen those delays across individual cells.
- The wider spread leaves some cells still repairing tissue while others already sustain scar-producing activity.
- A shared suppression time would therefore interrupt late repair while arriving too late to prevent early scar production.
- Reducing the timing spread at the same average response is predicted to create a wider period in which suppression preserves repair and limits scarring.
- That benefit is predicted to persist when YAP’s interaction with p73 is disrupted, separating this explanation from the rival requirement for late removal of damaged cells.
A shared closing bell cannot suit a workshop where some workers are still finishing essential repairs while others have already started adding unwanted material. Bringing their schedules closer together could create a better time to ring the bell.
Where the picture breaks: Cells do not follow assigned schedules, and YAP is not a simple stop switch. The picture does not establish that timing can be changed independently of the amount or kind of work cells perform.
- Master questionstep 01 of 04
A treatment is sought that would bring the functional condition of middle-aged human skin closer to that of young skin.
Rests on: The goal specifies the population and the desired comparison, but does not define which functions or degree of improvement would count as success.
Stated in the chain - Goal pillarstep 02 of 04
Limiting damage accumulated through repeated repair is selected as a route toward better skin function.
Rests on: The goal requires improved function, but does not identify repeated repair as the cause of its decline.
AssumptionThe chain assumes that damage accumulated through repeated repair contributes to the functional difference between middle-aged and young skin, and that limiting it would help close that difference.
- Gap questionstep 03 of 04
After repeated injury, suppressing YAP might prevent scarring while preserving strength, but the skin’s outer layer, deeper supporting layer, and structures such as hair follicles might need different intervention times.S5
Rests on: The repeated-repair concern is narrowed to the timing of scar prevention. S5, a 2025 Science Translational Medicine study, reports that a single treatment with verteporfin, described as a YAP inhibitor, immediately after wounding prevented scarring and promoted regeneration in pigs; it does not establish a safe timing range after repeated injury or compatibility across skin structures.
Supported by literature - Hypothesisstep 04 of 04
Different cells are proposed to activate YAP-controlled repair and scarring genes at increasingly different times after repeated injury. Reducing that timing spread while preserving the average response is predicted to widen the safe suppression period without requiring late YAP–p73-dependent programmed cell death.
Rests on: The preceding question supplies the possible timing conflict. The endpoint supplies its proposed explanation: random delays as groups of proteins assemble and disassemble to copy gene instructions into ribonucleic acid (RNA), the molecules through which those instructions are expressed. It also borrows a thermodynamic uncertainty relation, a conditional mathematical limit connecting the precision of reaction cycles to energy dissipation, meaning energy spent irreversibly; the supplied text explicitly leaves its relevance to skin repair unestablished.
Stated in the chain
What is carried, and what is not. None of the screened sources directly establishes any of the six proposed causal links; S5 supports the neighboring possibility of scar prevention through early YAP inhibition in pig wounds, with the limits stated above. S4, a 2019 Journal of Hepatology study, instead reports delayed repair and increased scarring after YAP inhibition in liver injury following interrupted and restored blood supply; that different setting cautions against treating inhibition as uniformly beneficial, and neither study establishes this sequence end to end.S5S4
Where the reasoning is carried by something unstated · 1
- Goal pillar. The chain assumes that damage accumulated through repeated repair contributes to the functional difference between middle-aged and young skin, and that limiting it would help close that difference.
How a result here could mislead · 3
- A wider safe period could be credited to reduced timing spread when the intervention actually changes the average response in particular cell groups. Matching averages across the whole sample could conceal those differences. What closes it: The design already requires matching average YAP levels inside the cell nucleus, selected repair and scarring gene outputs, cell divisions, and starting injury. Interpretation additionally requires checking timing spread and those averages within the relevant cell groups over time, rather than relying only on pooled measurements.
- Persistent benefit after an attempted disruption of YAP–p73 interaction could be read as evidence against the rival even if the interaction and late programmed cell death remain active. What closes it: Verify that the interaction was disrupted and measure the late cell-death response in the cells implicated by the rival. Without that verification, persistence of benefit cannot establish independence from this route.
- A wider range of start times preserving strength, reversible deformation, and barrier recovery could be called a scar-preventing window even if scarring is unchanged. What closes it: Measure scar formation alongside strength, recovery of shape after deformation, and the skin’s ability to restrict unwanted passage across its surface. Define success criteria and follow-up timing before testing; the supplied specification gives no thresholds and does not explicitly include scarring in its distinguishing prediction.
What would make this wrong. A verified reduction in the timing spread of YAP-controlled gene activity, with the specified average responses, cell divisions, and starting injury matched, that fails to widen the safe suppression period would refute timing variability as the determining mechanism. A benefit that specifically requires the late YAP–p73 interaction and associated cell death would contradict the proposed independence from that route and support the rival explanation.
What it would change. If the prediction held, intervention timing would depend partly on how widely individual cells’ responses are spread, rather than only on elapsed time since injury. Work toward younger skin function would then need to track and potentially control that spread while preserving useful repair. Results from isolated cells, small mixed cultures, or reconstructed skin would still not establish a treatment that restores middle-aged human skin to young function, and a timing benefit alone would not establish the borrowed physical limit as its cause.
Sources read · 9
Multi-omic analysis reveals divergent molecular events in scarring and regenerative wound healing. · Cell stem cell · 2022
“Transcriptional divergence between these two trajectories may occur as early as POD 2, with proteomic and histologic divergence following on POD 2/7 and 14, respectively.”
Does not settle: Источник не измеряет разброс времени активации YAP-зависимых программ в отдельных клетках, его изменение после повторного повреждения или причинную роль кинетики транскрипционных циклов. Он также не устанавливает безопасное окно подавления YAP, влияние снижения вариабельности при сохранении среднего ответа, участие YAP-p73-зависимого апоптоза либо показатели SPV_3 и SPV_4.
NUAK1 promotes organ fibrosis via YAP and TGF-β/SMAD signaling. · Science translational medicine · 2022
“Pharmacologic NUAK1 inhibition also reduced scarring, either when initiated immediately after injury or when initiated after fibrosis was already established.”
Does not settle: Источник не исследует межклеточный разброс сроков YAP-зависимой транскрипции, безопасные окна подавления YAP, восстановление после повторного повреждения или роль YAP-p73-зависимого апоптоза.
The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis. · Nature communications · 2022
“Importantly, inhibition of YAP/TAZ activity in obese mice markedly relieved AT fibrosis and improved metabolic homeostasis.”
Does not settle: Источник не устанавливает вариабельность времени активации YAP-зависимых программ между отдельными клетками, её изменение после повторного повреждения или безопасные окна подавления YAP. Описана фиброзная перестройка жировой ткани при ожирении, а не восстановление после повреждения и не SPV_3 или SPV_4.
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. · Journal of hepatology · 2019
“YAP activation suppressed extracellular matrix synthesis and diminished hepatic stellate cell (HSC) activation, whereas YAP inhibition significantly delayed hepatic repair, potentiated HSC activation, and enhanced liver fibrosis at 7 days post-IRI.”
Does not settle: The source does not test single-cell timing variability, reaction-cycle kinetics, repeated injury, suppression timing windows, SPV_3 or SPV_4, or whether reducing variability while preserving the mean response widens a safe suppression window.
Inhibiting mechanotransduction prevents scarring and yields regeneration in a large animal model. · Science translational medicine · 2025
“We show that one-time treatment with verteporfin, a YAP inhibitor, immediately after wounding is sufficient to prevent scarring and to drive wound regeneration in pigs.”
Does not settle: Источник показывает эффект однократного раннего подавления YAP в ранах свиней, но не измеряет разброс времени активации YAP-зависимых программ в отдельных клетках, его изменение после повторного повреждения, безопасные окна подавления или роль YAP-p73-зависимого апоптоза.
Controlling cardiac fibrosis through fibroblast state space modulation. · Cellular signalling · 2021
“However, this goal requires identification of cardiac fibroblast state trajectories during injury, repair, and recovery, along with the regulators of those state transitions.”
Does not settle: Обзор не устанавливает, что вариабельность сроков YAP-зависимой транскрипции определяет безопасное окно подавления YAP. Он не приводит данных о последовательной сборке транскрипционных комплексов, повторном повреждении, распределениях задержек, SPV_3, SPV_4 или YAP-p73-зависимом апоптозе.
Advances in RNA modification in myocardial fibrosis (Review). · International journal of molecular medicine · 2025
“It enhances Amotl1 mRNA stability and translational efficiency, promotes the binding of Amotl1 protein to YAP, and activates the Hippo/YAP signaling pathway, ultimately accelerating fibroblast proliferation and transdifferentiation.”
Does not settle: Источник не изучает межклеточный разброс сроков YAP-зависимых транскрипционных программ, повторное повреждение, окна подавления YAP или последствия подавления для восстановления и фиброза.
PDGFRα+/Integrin α2+ Fibroblasts Orchestrate Tumor Budding in Oral Squamous Cell Carcinoma via Mechano-Metabolic Symbiosis: E-Cadherin/Integrin α2β1 Adhesion and Mitochondrial Transfer. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
“This interaction is associated with cytoskeletal remodeling (α‐catenin/β‐catenin colocalization and elevated p‐MLC‐2 expression) and activation of YAP signaling, a key mediator of mechanical stress responses.”
Does not settle: Источник не устанавливает вариабельность времени YAP-зависимой транскрипции между клетками, её изменение после повторного повреждения или влияние подавления YAP на безопасное окно и заживление.
Topical Application of TT-10 Ameliorates Impaired Wound Healing. · Plastic and reconstructive surgery · 2025
“The authors' findings suggest that TT-10 facilitates the nuclear transport of YAP, consequently increasing YAP activity, which in turn increases the proliferation and migration of keratinocytes.”
Does not settle: Источник не исследует подавление YAP, межклеточную вариабельность сроков YAP-зависимой транскрипции, повторное повреждение, профибротические программы или безопасные временные окна вмешательства.
The gap this hypothesis explains
Two established results predict opposite outcomes, and both cannot be right.
After repeated skin injury, can protein suppression preserve strength and prevent scars, or do structures need conflicting schedules?
Original wording · exactly as the pipeline generated it
Существует ли после повторного повреждения окно подавления YAP, которое предотвращает рубцевание без потери прочности, или эпидермис, дерма и придатки требуют несовместимых моментов переключения?
What this question is asking
The question concerns whether the timing of suppressing Yes-associated protein (YAP), a protein involved in how cells respond to physical forces, can separate scar formation from the rebuilding needed for strong skin. It asks whether, after repeated injury, one treatment period can prevent scarring without reducing strength across the epidermis, the outer skin layer; the dermis, the supporting layer beneath it; and skin appendages, structures such as hair follicles and sweat glands. The decisive comparison is between a period compatible with all these structures and conflicting periods that protect one structure at another's expense. The question assumes that reducing force-related signals limits scarring, that insufficient YAP activity can impair repair, and that different skin structures recover on different schedules. Its broader functional targets include skin that returns to shape after deformation, sensation, sweating, and limited remaining stiffness, but the supplied material gives no numerical deadlines or acceptable limits.
- Yes-associated protein (YAP)
- A protein that helps regulate cellular responses, including responses to physical forces. Here it is the target of suppression; the supplied studies connect YAP-related activity with scar-forming repair in one setting and its inhibition with regeneration in another.
- YAP suppression or inhibition
- Reducing YAP activity. Drug treatment and genetic removal are different ways of doing this, and neither automatically establishes that suppression is temporary or equally strong in every skin structure.
- Treatment window
- A period after injury during which an intervention produces the desired combination of outcomes. A successful treatment at one time does not establish the earliest or latest effective time.
- Mechanical activation, force-related signalling, or mechanotransduction
- The process by which cells convert physical forces, such as stretching or tension, into biological signals. The question concerns whether reducing this process can limit scars while preserving repair.
- Epidermis
- The outer layer of skin. It is one of the structures whose repair timing the question asks to compare.
- Dermis
- The supporting skin layer beneath the epidermis. It contains cells and surrounding structural material involved in skin strength and scar formation.
- Skin appendages
- A collective name for structures associated with skin, including hair follicles and sweat glands. Recovery of appendages does not by itself demonstrate recovery of every type or of functions such as sweating.
- Fibroblasts
- Cells that produce and remodel much of the material supporting tissue. They are the cells in which YAP was specifically removed in one part of the mouse study.
- Matrix
- The material surrounding cells that provides structural support. Matrix degradation means breakdown of that material; the supplied sources do not establish the proposed connection between reduced tension and its degradation.
- Collagen
- A family of structural proteins in the material surrounding cells. Collagen contributes to tissue support and also accumulates during scar formation, so reduced accumulation alone does not establish preserved strength.
- Fibrosis
- Accumulation of fibrous supporting tissue, associated here with scarring. The supplied diabetic-mouse study reports that stimulating dermal fibrosis contributed to healing, illustrating why faster repair and less scarring are distinct outcomes.
- Regeneration
- Restoration of tissue structures following injury. The specific structures and functions recovered must be identified; the word alone does not establish complete restoration of skin function.
- Mechanical strength
- The ability of tissue to withstand physical force without failing. It differs from stiffness, which concerns resistance to deformation, and from the ability to return to shape afterward.
- Verteporfin
- A drug described in the supplied studies as an inhibitor of YAP. It was used to interfere with force-related signalling during wound repair.
- Genetic removal
- An alteration that eliminates a gene's function in the targeted cells. In the relevant mouse study, this targeted YAP in fibroblasts; it does not establish the effects of a reversible drug schedule throughout skin.
- VT107
- The compound tested in the preliminary scar-prevention study. The supplied abstract reports reduced scarring-related changes but does not establish a strength-preserving treatment period.
- Growth differentiation factor 11 (GDF11)
- A signalling protein applied to skin wounds in the supplied diabetic-mouse study. Its reported healing effect involved increased dermal fibrosis through a pathway including YAP.
- Diabetes
- A group of conditions involving impaired regulation of blood sugar. It defines the disease setting of the GDF11 mouse study and limits direct comparison with other wound settings.
Suppressing mechanical activation reduces scarring, insufficient YAP activity impairs repair, reduced tension supports matrix degradation, and different skin structures recover asynchronously, creating potentially incompatible intervention periods.
The assumption concerns how physical forces and YAP influence repair in the skin's outer layer, supporting layer, and embedded structures such as glands. It proposes that reducing these signals limits scars but can also weaken rebuilding or encourage breakdown of the material surrounding cells, with each structure needing the signals at a different time. If established, this would explain why treatment timing could determine whether scar prevention preserves skin function.
Blocking force-related signalling involving YAP reduced scarring in mouse and pig wound studies, supporting that part of the premise [S5, S8]. However, the mouse study also reports recovery of mechanical strength and skin appendages under YAP inhibition, which limits any blanket claim that inhibition necessarily compromises repair [S5]. A separate study reports improved healing partly through increased scar-forming tissue production involving YAP, but this does not establish that insufficient YAP causes impaired repair [S1]. The supplied sources do not establish reduced tension causing breakdown of the surrounding tissue material, asynchronous recovery requiring different treatment periods, or incompatible timing after repeated injury. These unsupported parts remain unestablished rather than refuted.S1S5S8
The same question asked without the part nothing read establishes:
- After repeated skin injury, is there a period of YAP suppression that reduces scarring while preserving strength and repair of the epidermis, dermis, and skin appendages?
- After repeated skin injury, how do the effects of YAP suppression on scarring, strength, and repair of different skin structures depend on treatment timing?
- A shared treatment period exists Suppressing YAP during that period would reduce scar formation while allowing the different skin structures to rebuild sufficiently to retain strength. This would establish compatibility for those outcomes after repeated injury, but would not by itself establish restored sensation or sweating.
- Skin structures require conflicting periods A period that reduces scar formation in one structure would overlap with a period when another needs YAP activity for repair. Applying the same suppression schedule throughout the skin would therefore trade scar reduction against repair or strength in another structure.
- No strength-preserving period is found Suppression might reduce scars only when strength is compromised, or it might fail to reduce scars after repeated injury. Either outcome would leave the desired combination unmet without establishing that conflicting schedules between structures caused the failure.
Repair must rebuild tissue that holds together under force while limiting the tissue changes that produce scars. One mouse study reports that blocking YAP-related signalling allowed recovery of skin structures and mechanical strength, so these outcomes were compatible in that setting [S5]. If this compatibility also held after repeated injury, reduced scarring could coexist with retained strength; if timing requirements conflicted, treating all skin structures during the same period could compromise some aspects of repair. Assuming compatibility from scar appearance alone would leave strength, sensation, sweating, and recovery after further injury unaccounted for.
Подавление механической активации уменьшает рубцевание в моделях, RL-1; недостаточная активность YAP ухудшает восстановление, а сниженное натяжение поддерживает деградацию матрикса.
Обратимая деформация, чувствительность и потоотделение восстанавливаются за заданные дни и недели; остаточная жёсткость после повторных циклов не превышает допустимый предел.
Не установлено, существует ли совместимое для прочности и предотвращения фиброза окно воздействия при неодновременном восстановлении разных структур кожи.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Проверяемая гипотеза: совместимость сроков подавления YAP определяется разбросом времени исполнения YAP-зависимых программ в отдельных клетках. Последовательная сборка и разборка транскрипционных комплексов создаёт случайные задержки. После повторного повреждения распределение этих задержек расширяется: часть клеток ещё исполняет программу восстановления, когда другие уже длительно поддерживают профибротическую программу. Единый момент подавления тогда одновременно прерывает восстановление в запаздывающих клетках и слишком поздно останавливает рубцевание в опережающих. Причинный носитель представляет собой кинетику реакционных циклов и распределение транскрипционных событий. Гипотеза предсказывает, что снижение внутренней вариабельности при сохранении среднего ответа расширит общее безопасное окно без необходимости позднего YAP–p73-зависимого апоптоза. Это должно стабилизировать SPV_3 и согласованность этапов заживления SPV_4.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Неравновесная термодинамика, термодинамическое соотношение неопределённости Барато–Зайферта: Var[Nτ]/⟨Nτ⟩² ≥ 2kB/Στ. Nτ обозначает суммарное число прямых прохождений выбранного реакционного цикла активации YAP-зависимой транскрипции за вычетом обратных за время τ; τ представляет собой интервал наблюдения при постоянных внешних условиях; угловые скобки и Var обозначают среднее и дисперсию по повторным траекториям; kB является постоянной Больцмана; Στ обозначает полное производство энтропии соответствующей реакционной системой вместе с её химическими резервуарами за этот интервал. При стационарных изотермических условиях Wdiss = TΣτ, где T является абсолютной температурой, а Wdiss представляет собой рассеянную свободную энергию. Следовательно, достижение относительной дисперсии не выше ε² требует Wdiss ≥ 2kBT/ε². [Первичная работа о термодинамической границе точности](https://doi.org/10.1103/PhysRevLett.114.158101). Применение предполагает стационарный марковский процесс с термодинамически согласованными переходами и достаточно длительное наблюдение. Число транскрипционных всплесков нельзя автоматически считать Nτ. Границу проверяют на стационарных участках записи; на весь меняющийся процесс заживления её напрямую не переносят. Предположение, что именно эта граница существенно ограничивает точность кожного восстановления, требует отдельной проверки.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
В одной серии моделей независимо изменяют начало подавления YAP и вариабельность транскрипционных ответов. Для сравнения подбирают режимы с одинаковыми средними уровнями ядерного YAP, средним выходом заранее выбранных восстановительных и профибротических генов, числом делений и исходным повреждением. Гипотеза предсказывает, что уменьшение разброса времени транскрипционных событий расширит диапазон начала подавления, при котором одновременно сохраняются прочность, обратимая деформация и восстановление барьера. Польза должна сохраняться при разобщении YAP–p73. Подтверждённое изменение вариабельности без изменения безопасного окна опровергнет её как определяющий механизм; специфическая зависимость результата от позднего YAP–p73-импульса поддержит IH_Q_L3_M_G4_2_01.
Would tell it apart from at least one rival. The prediction specifies a qualitative widening of the safe suppression window under matched conditions, persistence after YAP–p73 uncoupling, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Сначала используют отдельные клетки и небольшие совместные культуры с репортерами вновь синтезируемой РНК, затем реконструированную кожу. Управляемые воздействия позволяют искать пары режимов с сопоставимым средним ответом и разной вариабельностью; достижение такого сопоставления является условием интерпретации. Оценка диссипации конкретного транскрипционного цикла сложнее измерения колебаний экспрессии. Если обратные переходы или скрытые состояния не идентифицируются, термодинамическую часть можно оценить лишь частично.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
В одной серии моделей независимо изменяют начало подавления YAP и вариабельность транскрипционных ответов. Для сравнения подбирают режимы с одинаковыми средними уровнями ядерного YAP, средним выходом заранее выбранных восстановительных и профибротических генов, числом делений и исходным повреждением. Гипотеза предсказывает, что уменьшение разброса времени транскрипционных событий расширит диапазон начала подавления, при котором одновременно сохраняются прочность, обратимая деформация и восстановление барьера. Польза должна сохраняться при разобщении YAP–p73. Подтверждённое изменение вариабельности без изменения безопасного окна опровергнет её как определяющий механизм; специфическая зависимость результата от позднего YAP–p73-импульса поддержит Late Yes-associated protein activity may limit skin scarring by killing damaged repair cells.
- Rival 01 of 01What would separate them
Late Yes-associated protein activity may limit skin scarring by killing damaged repair cells predicts: В модели повторного повреждения сравнивают непрерывное подавление YAP, временное подавление с обычной отменой и тот же режим с коротким поздним восстановлением активности YAP. Гипотеза предсказывает, что поздний импульс уменьшит остаточную контрактуру и рубцевание при сохранении разрывной прочности. Эффект должен сопровождаться апоптозом предварительно меченных повреждённых миофибробластов и исчезнуть при избирательном нарушении взаимодействия YAP–p73. При этом ранняя миграция, средняя активность YAP–TEAD и вариабельность транскрипционных ответов должны быть сопоставимы. Сохранение пользы импульса после подтверждённого разобщения YAP–p73 опровергнет предложенный механизм. Если вместо этого исход определяется разбросом транскрипционных задержек, преимущество получит this hypothesis.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.